Molecular mechanisms of neuroprotection: The interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health
Behavioural Brain Research · 2025
DOI: 10.1016/j.bbr.2025.115545 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Behavioural Brain Research, 2025. Verfasst von Ravi Rana und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India; Affiliated to IK Gujral Punjab Technical Universi…. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Klotho Proteins, Sirtuin 1, Neuroprotection. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 263 Literaturangaben. Gefördert von: Department of Science and Technology, Ministry of Science and Technology, India, Science and Engineering Research Board.
Abstract (Originalsprache)
Neurological disorders significantly impair neuronal function and lead to cognitive and motor deficits. This review manuscript explores the therapeutic potential of key proteins-Klotho, SIRT-1, Nrf2, and HO-1-in combating these disorders. Neurological conditions encompass neurotraumatic, neurodegenerative, and neuropsychiatric diseases, all characterized by neuronal loss and dysfunction. The complex functions of Klotho, an anti-aging protein, and SIRT-1, a histone deacetylase, highlight their roles in neuronal survival and neuroprotection through the enhancement of antioxidant defences and the modulation of stress responses. Nrf2 functions as the principal regulator of the antioxidant response, whereas HO-1 facilitates the control of oxidative stress and the resolution of inflammation. Evidence suggests that the interplay between these proteins facilitates neuroprotection by decreasing oxidative damage and promoting cognitive function. The study emphasises the significance of signalling pathways, particularly the Nrf2/HO-1 axis, which are essential in mitigating oxidative stress and inflammation linked to neurodegenerative disorders. Future therapeutic strategies must consider personalized approaches, innovative drug delivery systems, and early intervention to optimize outcomes. This review provides a comprehensive framework for understanding how targeting these pathways can mitigate the burden of neurological disorders, advancing the development of effective interventions for enhancing brain health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India; Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab 144603, India.
- Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India; Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab 144603, India. Electronic address: sidharthmehan…
- Department of Pharmaceutics, ISF College of Pharmacy, Moga, Punjab, India; Affiliated to IK Gujral Punjab Technical University, Jalandhar, Punjab 144603, India.
- Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA.
Förderung
- Department of Science and Technology, Ministry of Science and Technology, India
- Science and Engineering Research Board
Zitieren
APA
Rana, R., Mukherjee, R., Mehan, S., Khan, Z., Das Gupta, G., & Narula, A. S. (2025). Molecular mechanisms of neuroprotection: The interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health. Behavioural Brain Research. https://doi.org/10.1016/j.bbr.2025.115545
Vancouver
Rana R, Mukherjee R, Mehan S, Khan Z, Das Gupta G, Narula AS. Molecular mechanisms of neuroprotection: The interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health. Behavioural Brain Research. 2025. doi:10.1016/j.bbr.2025.115545
BibTeX
@article{Rana2025,
author = {Rana, Ravi and Mukherjee, Ritam and Mehan, Sidharth and Khan, Zuber and Das Gupta, Ghanshyam and Narula, Acharan S},
title = {Molecular mechanisms of neuroprotection: The interplay of Klotho, SIRT-1, Nrf2, and HO-1 in neurological health},
journal = {Behavioural Brain Research},
year = {2025},
doi = {10.1016/j.bbr.2025.115545}
}
EUVIMED